Jackson Square Partners’s Charles River Laboratories CRL Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-134,927	Closed	-$24.9M	–	56
2024 Q4	$24.9M	Sell	134,927 -26,998	-17%	-$5.2M	2.59%	12
2024 Q3	$31.9M	Sell	161,925 -16,301	-9%	-$3.39M	2.75%	14
2024 Q2	$36.8M	Sell	178,226 -73,082	-29%	-$16.6M	2.25%	22
2024 Q1	$68.1M	Sell	251,308 -98,183	-28%	-$23.4M	2.83%	13
2023 Q4	$82.6M	Buy	349,491 +80,873	+30%	+$15.9M	2.68%	17
2023 Q3	$52.6M	Sell	268,618 -322,623	-55%	-$66.2M	1.76%	27
2023 Q2	$124M	Sell	591,241 -312,726	-35%	-$62.2M	3.63%	8
2023 Q1	$182M	Buy	903,967 +42,844	+5%	+$9.71M	4.93%	5
2022 Q4	$188M	Sell	861,123 -9,665	-1%	-$2.11M	5%	3
2022 Q3	$171M	Buy	870,788 +435,318	+100%	+$94M	4.49%	3
2022 Q2	$93.2M	Buy	435,470 +434,809	+65,780%	+$106M	2.18%	22
2022 Q1	$187K	Buy	+661	New	+$204K	﹤0.01%	93